Maksymowych Walter P, van der Heijde Désirée, Allaart Cornelia F, Landewé Robert, Boire Gilles, Tak Paul P, Gui Yuan, Ghahary Aziz, Kilani Ruhangiz, Marotta Anthony
Arthritis Res Ther. 2014 Apr 21;16(2):R99. doi: 10.1186/ar4547.
The aim of this study was to investigate whether 14-3-3η, a specific isoform of a family of proteins regulating processes such as cellular signalling, activates cell-signalling pathways and induces factors known to contribute to the pathophysiology of rheumatoid arthritis (RA). We also investigated whether 14-3-3η is associated with more severe disease in both early and established RA.
We investigated the effect of 14-3-3η on the activation of RA-relevant signalling cascades and induction of proinflammatory mediators that contribute to the joint damage process. 14-3-3η titres from 33 patients with early RA (mean RA duration = 1.8 months) and from 40 patients with established RA were measured in serum drawn at the 3-year time point of the Behandel Strategieën study. The relationship between 14-3-3η titres and standard clinical variables was investigated by correlation analysis. The association with radiographic damage and radiographic progression over at least a 2-year period was investigated using univariate and multivariate regression analyses.
14-3-3η activated selected members of the mitogen-activated protein kinase (MAPK) family, mainly extracellular regulated kinase 1/2 and c-Jun kinase, but not p38MAPK. Activation by 14-3-3η, using levels spanning the concentration range found in RA patient serum, resulted in the induction of inflammatory transcripts such as interleukin 1 (IL-1) and IL-6 and factors linked to the joint damage process, such as receptor activator of nuclear factor κB ligand and matrix metalloproteinase 1. Serum 14-3-3η correlated significantly with rheumatoid factor (RF) (r = 0.43) and anticitrullinated protein antibodies (ACPAs) (r = 0.31) in the early RA cohort, but not with C-reactive protein (CRP) or the Disease Activity Score in 28 joints in either cohort. Serum 14-3-3η concentrations were significantly higher in patients with radiographically assessed joint damage and in those who had radiographic progression. By multivariate analysis, we show that 14-3-3η complemented markers such as CRP, RF and ACPA in informing RA radiographic status and/or progression.
Extracellular 14-3-3η activates key signalling cascades and induces factors associated with the pathogenesis of RA at concentrations found in patients with RA, and its expression is higher in patients with radiographic damage and RA progression.
本研究旨在调查14-3-3η(一种调节细胞信号传导等过程的蛋白质家族的特定异构体)是否激活细胞信号通路并诱导已知促成类风湿关节炎(RA)病理生理学的因子。我们还研究了14-3-3η在早期和确诊的RA中是否与更严重的疾病相关。
我们研究了14-3-3η对与RA相关的信号级联激活以及对促成关节损伤过程的促炎介质诱导的影响。在Behandel Strategieën研究的3年时间点采集的血清中,测量了33例早期RA患者(平均RA病程 = 1.8个月)和40例确诊RA患者的14-3-3η滴度。通过相关分析研究14-3-3η滴度与标准临床变量之间的关系。使用单变量和多变量回归分析研究与至少2年期间的放射学损伤和放射学进展的相关性。
14-3-3η激活了丝裂原活化蛋白激酶(MAPK)家族的选定成员,主要是细胞外调节激酶1/2和c-Jun激酶,但不激活p38MAPK。使用RA患者血清中发现的浓度范围内的水平,14-3-3η的激活导致诱导炎症转录本,如白细胞介素1(IL-1)和IL-6,以及与关节损伤过程相关的因子,如核因子κB配体受体激活剂和基质金属蛋白酶1。在早期RA队列中,血清14-3-3η与类风湿因子(RF)(r = 0.43)和抗瓜氨酸化蛋白抗体(ACPA)(r = 0.31)显著相关,但在两个队列中均与C反应蛋白(CRP)或28个关节的疾病活动评分无关。在经放射学评估有关节损伤的患者和有放射学进展的患者中,血清14-3-3η浓度显著更高。通过多变量分析,我们表明14-3-3η在告知RA放射学状态和/或进展方面补充了CRP、RF和ACPA等标志物。
细胞外14-3-3η在RA患者中发现的浓度下激活关键信号级联并诱导与RA发病机制相关的因子,并且其表达在有放射学损伤和RA进展的患者中更高。